Vitek2
Payments companies reported to CMS as associated with Vitek2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vitek2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vitek2
These are the largest totals companies reported as associated with Vitek2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Trevor Vanschooneveld | Omaha, NE | Infectious Disease | $7,872.17 |
| Micah Bhatti | Houston, TX | Pediatric Infectious Diseases | $7,457.19 |
| Gordon Love | Miami, FL | Anatomic Pathology & Clinical Pathology | $111.47 |
| Dena Shibib | Oklahoma City, OK | Anatomic Pathology & Clinical Pathology | $102.74 |
| Angela Huttner | Salt Lake City, UT | Internal Medicine | $89.30 |
| Denver Niles | Houston, TX | Pediatric Infectious Diseases | $86.91 |
| Julio Figueroa | New Orleans, LA | Infectious Disease | $69.90 |
| Hai Nguyen-Tran | Aurora, CO | Pediatric Infectious Diseases | $65.00 |
| Raul Benavides | Dallas, TX | Clinical Pathology/Laboratory Medicine | $52.00 |
| Michael Climo | Richmond, VA | Infectious Disease | $47.79 |
Prescribed Vitek2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.